SureScan Pacing System Post-Approval Study (SureScan PAS)

Study ID
STU 102011-053

Cancer Related

Healthy Volunteers

Study Sites

  • UT Southwestern-Clinical Translational Research Center (CTRC)
  • Clements University Hospital

Anne Leyretana-Zabat

Principal Investigator
James Daniels, M.D.


The SureScan Pacing System PaS is a global, non-randomized, multi-center study. Subjects will be enrolled into either the Chronic Performance arm or Multiple MRi Scan arm. Subjects are eligible for enrollment into one arm of the study and will remain in the arm they are enrolled throughout their participation in the study. Data from subjects enrolled in the Chronic Performance arm Subjects will also contribute to the Multiple MRi Scn analysis. Subjects who participated in the enRhythm MRi iDe study are eligible for enrollment into the Multiple MRi Scan arm only.

The Version 4 protocol makes provision for patients who are implanted with an advisa MRi pacemaker to be enrolled in the study.

Participant Eligibility

1) Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements.
2) Subject is intended to be implanted with a complete SureScan pacing system consisting of both a right atrial and ventricular 5086MRI Lead (used for pacing and sensing) and a SureScan device
3) Subject within 30 days of implant (maximum 50% of prospective enrollment) or subject retrospectively enrolled (>30days post implant) with existing MRI indication.